North Carolina’s biotech clusters are truly unrivaled. From breakthrough technologies across life sciences to biopharmaceutical development and clinical research, hundreds of companies are leading the way toward sustained sector growth.
As a business leader, or employer of any type in North Carolina, you’re facing new challenges from the COVID-19 pandemic. EDPNC is here to help you navigate these unique economic challenges in the days ahead.
North Carolina's biotechnology industry runs deep and wide, with specialities ranging from pharmaceutical manufacturing and health informatics to crop genetic engineering. Comprised of 600+ companies and over 60,000 employees, our biotech cluster has grown 36 percent since 2001.
North Carolina’s biotech clusters are truly unrivaled. From breakthrough technologies across life sciences to biopharmaceutical development and clinical research, hundreds of companies are leading the way toward sustained sector growth.
Research Triangle Park (RTP), the largest research park in the U.S., is comprised of 200+ companies and 50,000+ employees with industry specializations including biotechnology and pharmaceuticals. RTP also is home to the North Carolina Biotechnology Center and the First Flight Venture Center.
Fueled by major Tier 1 research universities and top medical schools, North Carolina is a leading center for life science R&D. Duke University, the University of North Carolina at Chapel Hill, North Carolina State University, East Carolina University and Wake Forest University all contribute to an established workforce pipeline, active industry partnerships and an innovative business environment.
“As a long-established biotechnology hub that attracts the nation’s top talent, Research Triangle Park was an optimal location to expand our footprint.”
– Andrew Knudten, Senior VP of Technical Operations, AveXis
Click here to connect with our Business Development Team.